Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He wanted you to continue warfarin because he didn’t want the afib to return? Maybe for a short time after an ablation, but long term seems silly. I had an ablation to stop flutter, but also still have very periodic a-fib episodes (like once a year or 2 years). In many dealings with electrophysiologists, they tried to get me off blood thinners and have after a period of time after the ablation. For the record my experience with warfarin is negative because of the restrictions and blood tests.
Yep that and keeping their options open to partner in Europe or sell the entire company. Scripts going up substantially is the key for both. But it would make sense to keep both paths open pending script growth
There will be a Q&A after
Thanks for the link. Hopefully webcast link will work well and JT will give some good information
True, but i would think they are far more likely to do so if Amarin settles, which is why I hope they don’t (unless it is a great settlement for Amarin, giving up next to nothing)
Actually looks like Dr. Orringer was the one provided the perspective. It was a good read though, thanks for posting
Nope it is from Amarin being involved in a trial now and awaiting decision for at least 2-3 months. Using that uncertainty as reason to sell. On the other hand, if you have confidence in the trial outcome it’s going to be a great chance to add.
May want to check the Amarin patents
Maybe...just maybe JT isn’t the dope he is portrayed by some posters.
Yep, if you don’t have more to buy or think it’s not a good value then I would sell. Actually I would advise anyone who doesn’t believe in the management or the company to sell. The worst investment strategy in the world is evaluating an investment based on where you bought it. Looking real time at the potential of the stock and company prospects vs other potential investments is a much better way. If you think Amarin won’t succeed or at least won’t for a long while, then it’s decision time for those folks. Nothing wrong with selling.
It is a little bit of everything. It’s fake articles, it’s “experts” talking it down, it’s the overhang of the generics case and right now it’s likely people selling to go buy something else because of the uncertainty. The good news is that the price drop doesn’t mean management will be giving the company away any cheaper than they would otherwise, their valuation ask will still be the exact same. If you think the court case comes out well (which it certainly should), then use the dips to buy and then stop reading message boards and following the price daily if not by the minute.
Very good bounce back today. Hopefully able to hold $20. The huge buying near the close yesterday was nice to see. With that said expect attacks weekly if not daily. Either ignore the swings or trade them for your sanity
In the end I think the close was very good for 19 million shares traded and a lot of selling. It bounced back pretty well from the lows.
Perhaps it’s because you don’t understand how this works. No company is offering a buyout with pending litigation that could completely change the valuation. Seriously is this that hard to understand?
Those looking for buyout, there is about zero chance any company is going to make an offer before the generics case is settled, so right now it’s not even in the cards.
Unless they are just really inept, I think the Iranians missed on purpose from killing any Americans but can now also say they retaliated. I’m hopeful as all here the zero casualties holds throughout the night. If so I don’t expect much of a response from the US, and hopefully the markets calm.
Way over reaction. I hate after hours trading but I’m getting what I can in this 19.25-19.35 area. Shorts just used the news to go nuts.
If only this was how it works, but it isn’t. So many here have no clue about buyouts and selling companies. JT is not about to suddenly drop his ask for the company because the stock price moved a bit lower. The company has plenty of cash to operate well into the future and JT is exactly the kind of guy you want up against BP. He may not be the best salesman for sure, but his skill set will be invaluable in a sale.
That’s the problem is that people start buying for a buyout and it doesn’t come, or as quickly as they want, so mass selling occurs. Expectations aren’t realistic right now, the case isn’t even settled and no company is making a bid prior to it.
Yep he is my best fade. Whatever he says I go opposite
Every time we drop down near this $20 area I pick up shares to trade and also add to the investment. The lawsuit appears to be solidly in Amarin’s favor (nothing is a lock) and the the growth continues to come. Many just are impatient for a buyout, but shares at this price offer very good value to me whether we get buyout in near future or not. The downside of Amarin being a trading stock is these wild swings, but it can also be the upside.
Huh you think leadership is inept and yet you are invested?
Unfortunately not likely because Cramer has a horrible history of flip flopping, sometimes only a few days apart. He is an actor on a show
He can raise it at any time as he sees the growth plan fully working. Plenty of CEOs put low guidance, especially in the beginning stages. Far from an idiot, he just isn’t acting like you want him to. Thank god.
Nothing but a glorified hack. Get the fuck off the bus Cramer
This was a scheduled time from the court
Duke, Market makers in a typical day will look at the orders and get a sense of what the day will be. The case of $21 is more complicated than that, that is a round level in the trading world, $20, $21, $22 etc. in the absence of news and conviction from the market the market makers will help push the stock to test support levels or resistance to increase volume. Right now for example we are range bound in Amrn (and pre and post market are the true market, they really don’t count), so you will see the price of the stock oscillate back and forth from support where the big buy orders are likely to resistance where the bigger sell orders are. Amrn is 100% a trading stock and has been for a few years now so you will see bigger swings than most companies it’s size. What I’ve noticed is this $20.75-21.00 seems to have good support with larger purchases happening of late, but also that the news just isn’t there yet to lift it out of the upper end of this trading range. Many days you will see trading positions commingled with investors selling and buying in AMRN, so you have a confluence on issues to try to identify what the hell is actually happening.
Hi duke,
I’ve seen this speculated before that investors are putting in bids to hold a particular area. This could be happening and the lower volume trades is exactly how some of these guys operate, but it’s hard to say overall. In a stock like amrn what you will get is market maker small tells, like they keep bringing the offers down but the small bid doesn’t move, or you see 100 shares on the bid but it gets hit for 1000 in total without ever showing more than 100. What I noticed this morning that is good Amarin stock price is the 18k shares were offered at 20.47 were bought in almost one shot right before the open and than a few minutes later a 50k share offer was paid in 1 shot. Market makers don’t manipulate those type of big numbers. At the end of the day, demand will rule, but that demand has to be high enough or the market makers will move it back and forth like they normally do.
The best raf is when the analyst cuts the rating but raises the price target. Say cutting to hold but the price target is 30% higher. Who the hell wouldn’t invest in a stock expected to climb 30% ? That’s how you know analysts are dopes for the most part.
It doesn’t mean they don’t get more orders, but they clearly were using the order of almost 20k shares to push it lower. I’ve done it many many times. Give a large order and watch it get used, especially in illiquid times such as pre and post market
Market makers were using a big sell order to ride the market down premarket. That order has been filled now.
Welcome to the SEC who fell asleep a long time ago.
You will literally go bankrupt following analysts, or go insane. The majority of analysts would lose money on their calls because they are reactionary and not forward thinking enough. They also typically don’t have much insight into the company you can’t find on your own. On top of this they caveat the hell out of everything. If they were better at their jobs they would be investors
Not buying this big push down in either the overall market or AMRN. Good chance to pick up shares cheaply for later in the day
Actually it’s more than that. Amrn is a trading stock which gives it the volatility combined with there being a constant cloud overhead, be it real or made up. Panic is easy to achieve when the amount of weak hands exist on a daily basis in the stock
Unfortunately it is trading like AMRN. Good news is that the $21 area keep holding like a rock. Another day of swings.
We can all make up for it by seeing $50 a share in 2020 ??
They would also know he is very conservative in his numbers. This in no way is where they would settle on a buyout. How some on the board speak of M&A and how it actually works couldn’t be further from each other
Nope but getting the broader label approval is a good sign. Everything right now though seems to hinge of the generics lawsuit. Nonetheless, nice to see the stock price head in the right direction
Lol you may end up in a different kind of court.